These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2477864)

  • 21. Discriminative stimulus effects of reversible and irreversible opiate agonists: morphine, oxymorphazone and buprenorphine.
    France CP; Jacobson AE; Woods JH
    J Pharmacol Exp Ther; 1984 Sep; 230(3):652-7. PubMed ID: 6206224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of conditioned place preference or reinstatement with bivalent ligands containing mu-opioid receptor agonist and delta-opioid receptor antagonist pharmacophores.
    Lenard NR; Daniels DJ; Portoghese PS; Roerig SC
    Eur J Pharmacol; 2007 Jul; 566(1-3):75-82. PubMed ID: 17383633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An evaluation of morphine and oxymorphone administered via patient-controlled analgesia (PCA) or PCA plus basal infusion in postcesarean-delivery patients.
    Sinatra R; Chung KS; Silverman DG; Brull SJ; Chung J; Harrison DM; Donielson D; Weinstock A
    Anesthesiology; 1989 Oct; 71(4):502-7. PubMed ID: 2478049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of morphine, meperidine, and oxymorphone as utilized in patient-controlled analgesia following cesarean delivery.
    Sinatra RS; Lodge K; Sibert K; Chung KS; Chung JH; Parker A; Harrison DM
    Anesthesiology; 1989 Apr; 70(4):585-90. PubMed ID: 2467588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of histamine release induced by morphine and oxymorphone administration in dogs.
    Robinson EP; Faggella AM; Henry DP; Russell WL
    Am J Vet Res; 1988 Oct; 49(10):1699-701. PubMed ID: 2461130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spirohydantoin derivative of dimethoxytetrahydronaphthalene: an experimental anticonvulsant.
    Alexander GJ; Sinha B; Chatterjie N
    Neurochem Res; 1984 Apr; 9(4):529-33. PubMed ID: 6547772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 10-Ketonaltrexone and 10-ketooxymorphone.
    Archer S; Seyed-Mozaffari A; Ward S; Kosterlitz HW; Paterson SJ; McKnight AT; Corbett AD
    J Med Chem; 1985 Jul; 28(7):974-6. PubMed ID: 2409281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quaternary naloxone blocks morphine analgesia in spinal but not intact rats.
    Milne RJ; Coddington JM; Gamble GD
    Neurosci Lett; 1990 Jul; 114(3):259-64. PubMed ID: 1698268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Naloxone-6 alpha-spirohydantoin: a long-acting opiate antagonist.
    Alexander GJ; Chatterjie N
    Neurochem Res; 1989 Dec; 14(12):1229-34. PubMed ID: 2560821
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison between oxymorphone (Numorphan) and morphine sulfate prior to pentobarbital anesthesia in the dog.
    CLIFFORD DH; JHA SK
    Anesth Analg; 1961; 40():645-9. PubMed ID: 13879943
    [No Abstract]   [Full Text] [Related]  

  • 31. Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist.
    Bianchetti A; Giudice A; Picerno N; Carminati P
    Life Sci; 1982 Nov 15-22; 31(20-21):2261-4. PubMed ID: 6186879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of histamine release in human skin mast cells induced by morphine, fentanyl, and oxymorphone.
    Hermens JM; Ebertz JM; Hanifin JM; Hirshman CA
    Anesthesiology; 1985 Feb; 62(2):124-9. PubMed ID: 2578752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantum chemical studies of N-substituent variation in the oxymorphone series of opiate narcotics.
    Loew GH; Berkowitz DS
    J Med Chem; 1978 Jan; 21(1):101-6. PubMed ID: 73588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of analgesic drugs. V. The comparative subjective effects of oxymorphone and morphine.
    KEATS AS; TELFORD J
    Clin Pharmacol Ther; 1960; 1():703-7. PubMed ID: 13752110
    [No Abstract]   [Full Text] [Related]  

  • 35. Diastereomeric 6-desoxy-6-spiro-alpha-methylene-gamma-butyrolactone derivatives of naltrexone and oxymorphone. Selective irreversible inhibition of naltrexone binding in an opioid receptor preparation by a conformationally restricted michael acceptor ligand.
    Koolpe GA; Nelson WL; Gioannini TL; Angel L; Simon EJ
    J Med Chem; 1984 Dec; 27(12):1718-23. PubMed ID: 6209395
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
    Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
    Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the analgesic efficacy of hydromorphone and oxymorphone in dogs and cats: a randomized blinded study.
    Bateman SW; Haldane S; Stephens JA
    Vet Anaesth Analg; 2008 Jul; 35(4):341-7. PubMed ID: 18363580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The respiratory effects of oxymorphone administered alone or in combination with levallorphan.
    FOLDES FF; LUNN JN; KLEIN S; SIKER ES
    Am J Med Sci; 1962 Apr; 243():480-8. PubMed ID: 13893795
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of opioid analgesics on local cerebral glucose utilization.
    London E; Fanelli R; Szikszay M; Jasinski D
    NIDA Res Monogr; 1986; 75():379-81. PubMed ID: 2448633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opiates and their antagonists modulate luteinizing hormone acting outside the blood brain barrier.
    Panerai AE; Martini A; Casanueva F; Petraglia F; Di Giulio AM; Mantegazza P
    Life Sci; 1983 Apr; 32(15):1751-6. PubMed ID: 6188019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.